BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2008
View Archived Issues
Inspire initiates second phase III denufosol tetrasodium trial in cystic fibrosis
Read More
Cellegy enters definitive merger agreement with Adamis
Read More
Dara BioSciences and Point Therapeutics consummate merger
Read More
Altor signs agreement with Genentech for antibody-based tissue factor antagonists
Read More
Serotonin system involved in chronic L-DOPA wearing-off effect
Read More
Recent Amgen patent discloses new treatment for idiopathic pulmonary fibrosis
Read More
Results from Merck & Co. HIV vaccine reported at the CROI meeting
Read More
Sublingual route effective for influenza vaccine in mice
Read More
Robust immune responses with multiclade HIV-1 DNA plasmid vaccine in phase I/II studies
Read More
EMEA accepts for filing sanofi pasteur's MAA for seasonal influenza vaccine
Read More
Mesoblast reports positive results from clinical trial of adult stem cells in fracture healing
Read More
FDA issues special protocol assessment to Wilex for phase III trial of CA9-SCAN
Read More
Raven completes enrollment in phase I/IIa clinical trial of RAV-12 therapeutic antibody
Read More
Lipoxen and the Serum Institute of India initiate dosing in phase I trial of ErepoXen
Read More
Novel anti-HIV agents described in recent Merck patent
Read More
New therapeutic agents for HCV infection reported in recent patent literature
Read More
Bioniche presents update on Urocidin trial in refractory bladder cancer
Read More
FDA grants fast track status to Boehringer Ingelheim's BIBW-2992 for NSCLC
Read More
Qiagen and Center for Molecular Medicine research molecular diagnostic markers
Read More
YM Biosciences enrolls first patient in phase II nimotuzumab trial in brain cancer
Read More
Dainippon Sumitomo recaps Q3 developments
Read More
